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DNA contains 98250 bp composed of 16 coding exons. 
Transcription 
4828 bp mRNA transcribed in centromeric to telomeric 
orientation; 2649 bp open reading frame. 
Pseudogene 
Yes, for example, the repeat sequence named c41-cad 
is a pseudogene of the cadherin family. c41-cad is 
localizated on 5q13. 
 
DNA of CDH1 gene composed of 16 coding exons. 
Protein 
Description 
The cadherins are a family of calcium-dependent 
transmembrane linker proteins; the first three thatwere 
discovered were named according to their tissue origin 
(E-cadherin from epithelium, N-cadherin from neural 
tissue and P-cadherin from placenta). The mature E-
cadherin protein consists of three major domains: a 
large extracellular portion (exons 4-13), which 
mediates homophilic cellular interactions; and smaller 
transmembrane (exons 13-14) and cytoplasmic 
domains (exons 14-16), the latter providing a link to the 
actin cytoskeleton through an association with various 
catenins, such as B-catenin. The protein E-cadherin is a 
calcium-dependent cell-cell adhesion molecule 
expressed in adherents junctions between epithelial 
cells. It is a transmembrane glycoprotein with five 
extracellular domains that mediate intercellular 
adhesion through homophilic binding. The 
cytoplasmatic domain is bound to the actin 
cytoskeleton via intracellular attachment proteins, the 
catenins. The actin cytoskeleton forms a transcellular 
network mediating structural integrity, cellular polarity 
and epithelial morphogenesis. 
Expression 
Present tissue specificity for non-neural epithelial 
tissues and there are high levels in solid tissues. 
Localisation 
Cell junction; single-pass type I membrane protein. 
Anchored to actin microfilaments through association 
with alpha-catenin, beta-catenin and gamma-catenin. 
Sequential proteolysis induced by apoptosis or calcium 
influx, results in translocation from sites of cell-cell 
contact to the cytoplasm. 
Function 
One of the most important and ubiquitous types of 
adhesive interactions required for the maintenance of 
solid tissues is that mediated by the classic cadherin 
adhesion molecules. Cadherins are transmembrane 
Ca2+- dependent homophilic adhesion receptors that 
are well known to play important roles in cell 
recognition and cell sorting during development. 
However, they continue to be expressed at high levels 
in virtually all solid tissues. There are many membrs 
of the classic cadherin family (which is a subset of the 
larger cadherin superfamily), but E-cadherin in 
epithelial tissues has been the most studied in the 
context of stable adhesions. 
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Three-dimensional structure of the beta-catenin arm repeat region in complex with the E-cadherin cytoplasmic domain (Huber and Weis, 
2001). The arm repeats are formed by three helices, H1 and H2 (both gray) and H3 (blue). Residues 134-161, which include part of the 
alpha-catenin-binding site and a portion of the first arm repeat, form a single helix in this particular crystal structure (cyan). E-cadherin is 
divided into five regions of primary structure (1-5) that are indicated in distinct colors (Pokutta S and Weis WI, 2007). 
Continued expression and functional activity of E-
cadherin are required for cells to remain tightly 
associated in the epithelium, and in its absence the 
many other cell adhesion and cell junction proteins 
expressed in epithelial cells (see below) are not capable 
of supporting intercellular adhesion. In its capacity to 
maintain the overall state of adhesion between 
epithelial cells, E-cadherin is thought to act as an 
important suppressor of epithelial tumor cell 
invasiveness and metastasis. 
Homology 
Pan troglodytes - CDH1; Canis lupus familiaris - 
CDH1; Mus musculus - Cdh1; Rattus norvegicus - 
Cdh1; Gallus gallus - LOC415860; Danio rerio - cdh1. 
Mutations 
Germinal 
30 CDH1 germline mutations have been described in 
hereditary diffuse gastric cancer families. 25 have be n 
inactivating (frameshift, nonsense, and splice-site), the 
remainders are missense. The mutations are distributed 
equally throughout the gene. 
Somatic 
Somatically acquired mutations in CDH1 were found i 
about 56% of lobular breast tumors, generally (>90%) 
in combination with loss of the wild-type allele, while 
no mutations were found in ductal primary breast 
carcinomas. Most of these somatic mutations result in 
premature stop codons as a consequence of insertions, 
deletions and nonsense mutations. As the majority of 
these frameshift and nonsense mutations is predicted to 
generate secreted E-cadherin fragments, the 
functionality of this major cell-cell adhesion protein is 
lost. Other cancer-confined E-cadherin mutations also 
result in crippled proteins. The distinctive invasive 
growth pattern, which is typical for lobular breast 
cancers, is fully compatible with this functional 
inactivation. 
472 human tumors and 15 different cancer cell lines 
derived from 10 different tissues have been screened 
for CDH1 mutation. So far, frequent somatic mutations 
(50%) have been identified only in sporadic diffuse 
gastric cancer (DGC), Lobular Breast Cancer. For 
sporadic DGC, most somatic mutations are missense 
(exons 8, 9) or exon skipping. For sporadic Lobular 
Breast Cancer, most somatic mutations are 
truncating.472 human tumors and 15 different cancer 
cell lines derived from 10 different tissues have been 
screened for CDH1 mutation. So far, frequent somatic 
mutations (50%) have been identified only in sporadic 
Diffuse Gastric Cancer, Lobular Breast Cancer. 
Interestingly, there is a major difference between the 
mutation types identified in these two carcinoma types. 
In diffuse gastric carcinomas, the predominant 
mutations are exon skippings causing in-frame 
deletions. By contrast, most mutations identified in 
lobular breast cancer result in premature stop codons. 
In the case of the diffuse gastric carcinomas, a mutation 
cluster region is suggested as more than 60% of 
mutations cause exon skipping of exon 8 and 9. 
Preliminary in vitro studies using transfected cell lines 
suggest that tumor-associated E-cadherin mutations 
reduce cell adhesion, increase cell motility, and change 
cell morphology possibly by dominant negative 
mechanisms. 
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57 CDH1 mutations have been found to date. 50 of these are listed in Human Gene Mutation Database. Truncating (27) and splice site 
(7) mutations are found above the Schema (34/45, 76%), missense mutations below it (11/45, 24%). Two marked with an asterisk have 
been reported as somatic mutations in sporadic diffuse gastric cancer. No Polymorphisms. No Gross deletions/duplications, complex 
rearrangements, repeat variations been reported. They spread out all over CDH1 gene (Brooks-Wilson et al., 2004). 
On the contrary, the truncating mutations present in 
lobular breast cancers are obviously scattered overthe 
entire E-cadherin gene. In line with this finding is the 
observation that the expression of E-cadherin protein is 
lost in lobular breast cancers, in contrast to the 
retention of expression of the mutant E-cadherin 
proteins in diffuse gastric carcinomas. Surprisingly, so 
far almost no E-cadherin mutations have been found to 
be located in the highly conserved cytoplasmic domain. 
In most cases, E-cadherin mutations are found in 
combination with loss of the wild-type allele. 
Implicated in 
Non-small cell lung cancer 
Prognosis 
Reduced E-cadherin correlates with lymph node 
metastasis. The rate of vascular invasion was 
statistically high in cases with the reduced expression 
of E-cadherin. Reduction of E-cadherin is associated 
with the degree of differentiation. Bohm et al. found a 
correlation between differentiation and E-cadherin 
expression in lung squamous cell carcinoma, and 
Bongiorno et al. found that well-differentiated lung 
cancers express E-cadherin, in a preserved fashion, and 
that poorly differentiated tumors exhibited a reduced or 
disorganized staining pattern. Sulzer et al. also found 
that E-cadherin expression significantly correlated with 
increasing tumor differentiation. In general, 
undifferentiated or poorly differentiated cancer cells 
tend to have a strong potential to invade tissues. These 
results suggest that reduction of E-cadherin correlates 
with tumor invasion. 
Oncogenesis 
Reduced E-cadherin expression weakens cell-to-cell 
attachment, and tumor cells detach from the primary 
tumor, invade vessels, and migrate to lymph nodes. 
Once tumor cells reattach to lymph nodes, E-cadherin 




The major adhesion mediator between keratinocytes 
and normal melanocytes is E-cadherin, which 
disappears during melanoma progression. While 
normal melanocytes express E-cadherin, this molecule 
is not found on nevus or melanoma cells. The loss of E-
cadherin likely plays a crucial role in tumor 
progression. Cells that have lost epithelial 
differentiation, as manifested by the loss of functional 
E-cadherin, show increased mobility and invasiveness. 
Keratinocytes can no longer control melanoma cells 
that have lost E-cadherin. When melanoma cells are 
forced to express E-cadherin and are cocultured with
keratinocytes, they dramatically change: melanomas 
adhere to keratinocytes, no longer express invasion-
related molecules, and lose their invasive capacities 
Oesophageal adenocarcinoma 
Prognosis 
Reduction in the expression of E-cadherin in patients 
with OSCC was shown to be strongly associated with 
postoperative blood borne recurrence, resulting in a 
poorer prognosis than in those patients with tumours 
showing normal expression before surgery.  
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This finding suggested that in patients with reduced E-
cadherin immunoreactivity, the metastatic potential of 
the oesophageal cancer cells may be increased. 
Therefore, the evaluation of E-cadherin 
immunoreactivity may be useful in predicting 
haematogenous spread and hence recurrence, thus 
serving as an aid for planning adjuvant treatment after 
surgery in patients with OSCC. It has also been 
reported that E-cadherin might be an independent 
predictor of micrometastasis in lymph nodes that are 
classified as N0 by routine histopathological analysis. 
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